APG-115 in Patients With Advanced Solid Tumors or Lymphomas
Clinical trial NCT02935907 · COMPLETED
Trial details
- NCT number
- NCT02935907
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2019-06-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.